---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-24-012340"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T21:10:32.983579+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro announces 1-for-10 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective July 16, 2024; reduces outstanding shares from ~7.98M to ~798K.
- Split aims to meet Nasdaq minimum bid price of $1.00 per share.
- No fractional shares; cash payments for fractional shares via Computershare.
- Authorized shares and par value ($0.0001) unchanged.
- Stockholders authorized split range 1:2 to 1:20 in April; board set 1:10 in June.

## SEC filing metadata
- accession: 0001214659-24-012340
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/0001214659-24-012340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/b7112428k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-24-012340
- JSON: https://secwatch.observer/filing/0001214659-24-012340.json
- Plain text: https://secwatch.observer/filing/0001214659-24-012340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.